When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BLPH - Bellerophon sets late-stage study of INOpulse for PH; shares up 12%
Bellerophon Therapeutics Inc.
Based on FDA feedback, Bellerophon Therapeutics (BLPH+12%) has set the key aspects of its planned Phase 3 clinical trial evaluating INOpulse for the treatment of pulmonary hypertension associated with pulmonary fibrosis.
More news on: Bellerophon Therapeutics, Inc., Healthcare stocks news, Stocks on the move,